Dolby Laboratories (DLB) Tops Q2 EPS by 16c; Guides Q3 Above Views

Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $0.63, $0.16 better than the analyst estimate of $0.47. Revenue for the quarter came in at $267.5 million versus the consensus estimate of $275.81 million.

GUIDANCE:

Dolby Laboratories sees Q3 2017 EPS of $0.75-$0.81, versus the consensus of $0.64. Dolby Laboratories sees Q3 2017 revenue of $290-305 million, versus the consensus of $293.3 million.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
• Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c